Earn an 11% return p.a. over two years with EBI Fixed Income
At Ethical Bioscience Investments, we offer fixed rates of return for qualified investors looking to invest across the global bioscience sector during a critical moment for healthcare innovation.
As we enter historically low interest rate environments, there’s never been a better time to achieve consistent, high-yield financial returns while positively impacting the future of global healthcare.
With our EBI Fixed Income financial product, investors can now take advantage of our global portfolio of diversified investments across the biotechnology sector, carefully selected and validated by our in-house scientific and investment banking experts.
| FIXED INVESTMENT TERM (P.A.) | 7% | 9% | 11% |
|---|---|---|---|
| INVESTMENT TERM | 6 months | 12 months | 24 months |
| ^EBI Fixed Income Notes are exclusively available to sophisticated/wholesale investors only. Minimum investment amount of $50,000.00 applies and allocations are limited. | |||
| COUPON RATE (P.A.) | INVESTMENT TERM |
|---|---|
| 7% | 6 months |
| 9% | 12 months |
| 11% | 24 months |
| ^EBI Fixed Income Notes are exclusively available to sophisticated/wholesale investors only. Minimum investment amount of $50,000.00 applies and allocations are limited. | |
Request Further Information
For further information and to receive a copy of our brochure, please complete the form below.EBI Fixed Income Calculator
Investment Amount
Investment Term
Interest Rate
TOTAL INTEREST EARNED OVER 6 Month TERM
Quarterly DISTRIBUTION
Why Invest With EBI?
NO MANAGEMENT, SET UP OR HIDDEN FEES
OPPORTUNITY TO INVEST IN ROBUST GLOBAL BIOSCIENCE SECTOR
INVEST IN PRODUCTS VETTED BY TRUSTED EXPERTS
ACCELERATE THE DEVELOPMENT OF FUTURE MEDICINES
Investment Philosophy
At Ethical Bioscience Investments, our scientific and investment committees only invest in companies with a clear competitive advantage.
Ethical Bioscience Investments holds a competitive advantage when reviewing investments within the bioscience sector.
The iQ Group Global is a unique enterprise that converges bioscience with investment banking and commercialization to accelerate innovation and bring new therapeutic interventions to the world. This gives Ethical Bioscience Investments the capability to make informed and educated investments, add value to investee companies, and mitigate downside risk for investors to positively impact the future of healthcare. Our investment doctrine stems from our validation trinity: Science, People, Financials.
Science: Our experts validate the scientific merit of the innovation and the viability of the proposed development plan.
People: We know that it takes great people to create and sustain great companies. In our due diligence, we seek proof that the leaders of the companies we invest in have the will, capabilities and capacity to do just that.
Financials: We select investments based on their financial and industry position, as well as market and economic conditions.
The Bioscience Sector
With global healthcare under unprecedented pressure, innovation in medicine must accelerate like never before.
Population increase, rising life expectancy, urbanisation and the spread of infectious diseases demand a new frontier for bioscience innovation to ensure the right medicines are developed when the world needs them most.
At Ethical Bioscience Investments, we invest across the entire bioscience sector – from chemical, biologic, genetic pharmaceutical interventions, to advanced point of care diagnostics, medicine nanorobotics, all at the forefront of medical research.
As a subsidiary of The iQ Group Global, we hold a competitive advantage when reviewing investments within the bioscience sector. The iQ Group Global is a unique enterprise that converges bioscience with investment banking and commercialisation to accelerate innovation and bring new therapeutic interventions to the world. This gives Ethical Bioscience Investments the rare capability to make informed and educated investments, add value to investee companies, and mitigate downside risk for investors to positively impact the future of healthcare.
Expert Leadership
The expertise of our Investment Committee, Scientific Advisory Board and Management Team goes beyond the typical qualifications and experience of investment managers. As active investors and bioscience industry leaders across the entire research and development cycle, we are enabled to oversee the value development of our investee companies and to identify the value creation events for divestment opportunities.
